158 related articles for article (PubMed ID: 16047477)
1. Effect of concomitant polyethylene glycol and celecoxib on colonic aberrant crypt foci and tumors in F344 rats.
Do K; Barnard GF
Dig Dis Sci; 2005 Jul; 50(7):1304-11. PubMed ID: 16047477
[TBL] [Abstract][Full Text] [Related]
2. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
[TBL] [Abstract][Full Text] [Related]
3. Fructooligosaccharide associated with celecoxib reduces the number of aberrant crypt foci in the colon of rats.
Buecher B; Thouminot C; Menanteau J; Bonnet C; Jarry A; Heymann MF; Cherbut C; Galmiche JP; Blottière HM
Reprod Nutr Dev; 2003; 43(4):347-56. PubMed ID: 14971826
[TBL] [Abstract][Full Text] [Related]
4. Polyethylene-glycol, a potent suppressor of azoxymethane-induced colonic aberrant crypt foci in rats.
Corpet DE; Parnaud G
Carcinogenesis; 1999 May; 20(5):915-8. PubMed ID: 10334212
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of NS-398, a selective cyclooxygenase-2 inhibitor, on azoxymethane-induced aberrant crypt foci in colon carcinogenesis of F344 rats.
Yoshimi N; Kawabata K; Hara A; Matsunaga K; Yamada Y; Mori H
Jpn J Cancer Res; 1997 Nov; 88(11):1044-51. PubMed ID: 9439679
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of azoxymethane-induced colorectal cancer by CP-31398, a TP53 modulator, alone or in combination with low doses of celecoxib in male F344 rats.
Rao CV; Steele VE; Swamy MV; Patlolla JM; Guruswamy S; Kopelovich L
Cancer Res; 2009 Oct; 69(20):8175-82. PubMed ID: 19826045
[TBL] [Abstract][Full Text] [Related]
7. Consistent and fast inhibition of colon carcinogenesis by polyethylene glycol in mice and rats given various carcinogens.
Corpet DE; Parnaud G; Delverdier M; Peiffer G; Taché S
Cancer Res; 2000 Jun; 60(12):3160-4. PubMed ID: 10866305
[TBL] [Abstract][Full Text] [Related]
8. Suppression of occurrence and advancement of beta-catenin-accumulated crypts, possible premalignant lesions of colon cancer, by selective cyclooxygenase-2 inhibitor, celecoxib.
Yamada Y; Yoshimi N; Hirose Y; Hara A; Shimizu M; Kuno T; Katayama M; Qiao Z; Mori H
Jpn J Cancer Res; 2001 Jun; 92(6):617-23. PubMed ID: 11429049
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of caffeic acid esters on azoxymethane-induced biochemical changes and aberrant crypt foci formation in rat colon.
Rao CV; Desai D; Simi B; Kulkarni N; Amin S; Reddy BS
Cancer Res; 1993 Sep; 53(18):4182-8. PubMed ID: 8364913
[TBL] [Abstract][Full Text] [Related]
10. Polyethylene glycol reduces inflammation and aberrant crypt foci in carcinogen-initiated rats.
Karlsson PC; Hughes R; Rafter JJ; Bruce WR
Cancer Lett; 2005 Jun; 223(2):203-9. PubMed ID: 15896454
[TBL] [Abstract][Full Text] [Related]
11. Dietary inulin suppresses azoxymethane-induced aberrant crypt foci and colon tumors at the promotion stage in young Fisher 344 rats.
Verghese M; Rao DR; Chawan CB; Williams LL; Shackelford L
J Nutr; 2002 Sep; 132(9):2809-13. PubMed ID: 12221250
[TBL] [Abstract][Full Text] [Related]
12. Dietary inulin suppresses azoxymethane-induced preneoplastic aberrant crypt foci in mature Fisher 344 rats.
Verghese M; Rao DR; Chawan CB; Shackelford L
J Nutr; 2002 Sep; 132(9):2804-8. PubMed ID: 12221249
[TBL] [Abstract][Full Text] [Related]
13. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis.
Kawamori T; Rao CV; Seibert K; Reddy BS
Cancer Res; 1998 Feb; 58(3):409-12. PubMed ID: 9458081
[TBL] [Abstract][Full Text] [Related]
14. Polyethylene glycol, unique among laxatives, suppresses aberrant crypt foci, by elimination of cells.
Taché S; Parnaud G; Van Beek E; Corpet DE
Scand J Gastroenterol; 2006 Jun; 41(6):730-6. PubMed ID: 16716974
[TBL] [Abstract][Full Text] [Related]
15. Suppression of azoxymethane-induced rat colon aberrant crypt foci by dietary protocatechuic acid.
Kawamori T; Tanaka T; Kojima T; Suzui M; Ohnishi M; Mori H
Jpn J Cancer Res; 1994 Jul; 85(7):686-91. PubMed ID: 8071110
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of d-limonene on the development of colonic aberrant crypt foci induced by azoxymethane in F344 rats.
Kawamori T; Tanaka T; Hirose Y; Ohnishi M; Mori H
Carcinogenesis; 1996 Feb; 17(2):369-72. PubMed ID: 8625465
[TBL] [Abstract][Full Text] [Related]
17. Chemopreventive effect of 2-(allylthio)pyrazine (2-AP) on rat colon carcinogenesis induced by azoxymethane (AOM).
Kim DJ; Kang JS; Ahn B; Kim KS; Park KH; Choi KS; Surh YJ; Kim ND
Cancer Lett; 2001 May; 166(2):125-33. PubMed ID: 11311484
[TBL] [Abstract][Full Text] [Related]
18. Molecular changes in the early stage of colon carcinogenesis in rats treated with azoxymethane.
Kishimoto Y; Morisawa T; Hosoda A; Shiota G; Kawasaki H; Hasegawa J
J Exp Clin Cancer Res; 2002 Jun; 21(2):203-11. PubMed ID: 12148579
[TBL] [Abstract][Full Text] [Related]
19. Unexpected antagonistic action of 3,2'-dimethyl-4-aminobiphenyl on aberrant crypt induction by 1,2-dimethylhydrazine or azoxymethane in rat colon.
Steffensen IL; Paulsen JE; Alexander J
Carcinogenesis; 1995 Dec; 16(12):2981-8. PubMed ID: 8603473
[TBL] [Abstract][Full Text] [Related]
20. Ursodeoxycholic acid and F(6)-D(3) inhibit aberrant crypt proliferation in the rat azoxymethane model of colon cancer: roles of cyclin D1 and E-cadherin.
Wali RK; Khare S; Tretiakova M; Cohen G; Nguyen L; Hart J; Wang J; Wen M; Ramaswamy A; Joseph L; Sitrin M; Brasitus T; Bissonnette M
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1653-62. PubMed ID: 12496057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
